The global DNA Repair Drugs market was valued at 503.77 Million USD in 2020 and will grow with a CAGR of 18.75% from 2020 to 2027, based on a newly published report.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body`s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
Get Sample PDF with Latest Insights at https://www.worldwidemarketreports.com/sample/719536
DNA repair drugs are used to repair damaged DNA and to treat cancer. These drugs are often used to treat diseases with genetic aberrations. DNA repair drugs such as Rucaparib (Rubraca), Olaparib (Lynparza), Talazoparib (Talzenna), and Niraparib (Zejula) are used to treat ovarian cancer and breast cancer. These drugs fall under the category of Poly ADP-ribose Polymerase (PARP) inhibitors used in combination with other drugs to treat cancer. DNA repair is a process in which a cell recognizes and repair damaged DNA that encode its genome.
Market Vendors Covered in DNA Repair Drugs Market Report:
4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group, GlaxoSmithKline, Jiangsu Hengrui Medicine, Johnson & Johnson, Jonsson Comprehensive Cancer Center, Karyopharm Therapeutics, KuDOS Pharmaceuticals, National Health Service, National Institutes of Health, Tesaro
Increasing demand for DNA repair drugs due to rise in prevalence of cancer around the world is expected to propel growth of the global DNA repair drugs market over the forecast period. For instance, according to the World Health Organization (WHO), Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common cancer in 2020 (in terms of new cases) were: breast (2.26 million cases).
Moreover, government initiatives to promote awareness for cancer treatment, increasing drug approvals, and increasing adoption of technologically advanced products are expected to boost the growth of the global DNA repair drugs market.
- PARP Inhibitors
If you have any query related to DNA Repair Drugs market report, you can ask to our expert at https://www.worldwidemarketreports.com/quiry/719536
North America is expected to witness robust growth in the global DNA repair drugs market due to increasing prevalence of cancer and increasing demand for DNA repair drugs in this region. For instance, according to the American Cancer Society, in 2021, about 21,410 women in the United States will receive a new diagnosis of ovarian cancer and 13,770 women will die from ovarian cancer. Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system.
Table of Content Covered in DNA Repair Drugs Market Report
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global DNA Repair Drugs Market Size Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: DNA Repair Drugs Industry Impact
Chapter 2 Global DNA Repair Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global DNA Repair Drugs (Volume and Value) by Type
2.2 Global DNA Repair Drugs (Volume and Value) by Application
2.3 Global DNA Repair Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global DNA Repair Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global DNA Repair Drugs Consumption by Regions (2016-2021)
4.2 North America DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America DNA Repair Drugs Sales, Consumption, Export, Import (2016-2021)
Request Discount on DNA Repair Drugs Market Report at https://www.worldwidemarketreports.com/discount/719536
Chapter 14 Company Profiles and Key Figures in DNA Repair Drugs Business
Chapter 15 Global DNA Repair Drugs Market Forecast (2022-2027)
15.1 Global DNA Repair Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.2 Global DNA Repair Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.3 Global DNA Repair Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.4 Global DNA Repair Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 DNA Repair Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Purchase this DNA Repair Drugs Report to Access Full Information at https://www.worldwidemarketreports.com/buy/719536
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provides our diverse range of clients from across all industries with vital decision-making insights to plan and align their market strategies in line with current market trends.
Worldwide Market Reports,
Tel: U.S. +1-415-871-0703